Research at Cain

Late stage mTOR inhibition is sufficient to reverse established epilepsy

03/25/2015

Many pediatric cases of incurable epilepsy are attributed to a congenital defect, known as cortical dysplasia (CD) in which the neurons fail to migrate to appropriate locations in the brain during development. This results in abnormal brain architecture and neuronal miswiring that manifests as severe seizures. Currently, no treatments exist to prevent this condition and the only option is to reduce seizures using anticonvulsants or neurosurgery.

more

NRI conference accelerates next phase of research on catastrophic epilepsy

11/20/2014

Dr. John Swann, co-director of the Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Children’s and Baylor College of Medicine, co-authored an article in Science Translational Medicine that highlights key research findings presented earlier this year at the NRI conference on catastrophic childhood epilepsy.

more

Many roads to hyperexcitation: mTOR suppressors regulate synaptic function in different ways

11/17/2014

Loss of 2 genes that repress mechanistic Target of Rapamycin (mTOR), a growth-promoting pathway, causes autism and epilepsy. Excessive excitation of neurons was assumed to be the culprit. However, a study published in the February 2014 issue of The Frontiers in Molecular Neuroscience adds a new twist.

more